← All trials
NCT06819735
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 25, 2025
- Primary completion
- Sep 30, 2027
- Completion date
- Jan 31, 2028
- First posted
- Feb 11, 2025
- Last posted
- Nov 18, 2025
- Enrollment
- 125
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Domain Therapeutics Australia Pty LtdLead sponsor
- Domain Therapeutics SACollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.